Current Issue
Meralgia Paresthetica Successfully Treated with Palmithoylethanolamide
by Rocco Salvatore Calabrò MD, PhD; Carmela Casella, MD; Alfredo Manuli, MSc; David Militi, MD; and Giuseppe Gervasi, MD, PhD Drs. Calabrò and Manuli are with IRCCS Centro Neurolesi “Bonino Pulejo” in Messina, Italy. Dr. Casella is with Policlinico University in Messina, Italy. Dr. Militi is with Stomato-dental Laboratory in Messina, Italy. Dr. Gervasi is […]
A Flash of Hope: Eye Movement Desensitization and Reprocessing
by Danielle Gainer, MD; Sarah Alam, BS; Harris Alam; and Hannah Redding, BA Dr. Gainer, Sarah Alam, and Ms. Redding are with Wright State University Boonshoft School of Medicine in Fairborn, Ohio. Harris Alam is with University of Central Florida in Orlando, Florida. FUNDING: No funding was provided. DISCLOSURES: The authors have no conflicts of […]
Behavioral Activation Contributed to the Total Reduction of Depression Symptoms in the Smartphone-based Cognitive Behavioral Therapy: A Secondary Analysis of a Randomized, Controlled Trial
by Hissei Imai, MD, PhD; Mitsuhiko Yamada, MD, PhD; Masatoshi Inagaki, MD, PhD; Norio Watanabe, MD, PhD; Bun Chino, MD, PhD; Akio Mantani, MD, PhD; and Toshiaki A Furukawa, MD, PhD Drs. Imai, Watanabe, and Furukawa are with the Department of Health Promotion of Human Behavior at Kyoto University Graduate School of Medicine / School […]
Latency to First Event is Shorter in Psychogenic Non-epileptic Seizures Than in Epileptic Seizures in an Epilepsy Monitoring Unit
by Vishwanath Sagi MBBS, MPH; Jaime Shoup MD; Ravikiran Chilukuri; and M. Steven Evans MD Drs. Sagi and Evans are with the Department of Neurology at the University of Louisville in Louisville, Kentucky. Drs. Shoup and Chilukuri are with the University of Louisville School of Medicine in Louisville, Kentucky. FUNDING: No funding was provided for […]
The Depression Inventory Development Scale: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial
by Anthony L. Vaccarino, PhD; Amir H. Kalali, MD; Pierre Blier, MD, PhD; Susan Gilbert Evans, MSc; Nina Engelhardt, PhD; Jane A. Foster, PhD; Benicio N. Frey, MD, PhD; John H. Greist, MD; Kenneth A. Kobak, PhD; Raymond W. Lam, MD, FRCPC; Glenda MacQueen, MD, PhD, FRCPC; Roumen Milev, MD, PhD, FRCPsych, FRCPC; Daniel J. […]
Layperson/Plain Language Summaries: Can Sponsors, CROs, and Sites Deliver in 2020?
by Charles S. Wilcox, PhD, MPA, MBA; Leslie Franceschi, BA; and ADAM SIMMONS, MPH Dr. Wilcox is Chief Executive Officer at Praxis Research Consulting in Newport Beach, California. Ms. Franceschi is Senior Project Director at Syneos Health in Morrisville, North Carolina. Mr. Simmons is Director of Clinical Program Management at Alkermes Inc. in Boston, Massachusetts. […]
Risk Management: Top Five HIPAA Lessons Learned: A Review of HHS Resolution Agreements
by Justin Pope, JD Mr. Pope is an Associate Risk Manager at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article. DISCLOSURES: The author is an employee of PRMS Inc., a risk-management consulting company for health care providers. This ongoing column is dedicated to providing information to our […]
Frontiers in Detecting Consciousness: The Growing Use of EEG Analysis
Dear Editors: There is growing scientific interest regarding the use of electroencephalogram (EEG) and multivariate analysis as a means to classify states of consciousness. A recent work assessed the validity of 28 potential EEG markers of consciousness, using the Disorders of Consciousness (DoC)-Forest (the name of the algorithm) tool, to establish states of awareness in […]
Role of Norepinephrine in Schizophrenia: An Old-fashioned but New Story from Emergency Medicine
Dear Editor: A number of hypotheses have been put forth regarding the etiology of schizophrenia, including dopamine hypothesis and glutamate hypothesis.1 However, a lesser known theory is that elevated norepinephrinergic signaling plays a causative role in schizophrenia.2 We treated a patient with septic shock schizophrenia who developed delusions and hallucinations following continuous norepinephrine infusion. This […]
